Revolution Medicines Inc (RVMD)
NASDAQ · Healthcare · Biotechnology
Revolution Medicines Inc is a Healthcare company with a market capitalization of $42.92B.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $-2.29 | $-1.84 | -24.5% |
| Q4 2025 | February 25, 2026 | $-1.86 | $-1.58 | -17.7% |
| Q3 2025 | November 5, 2025 | $-1.61 | $-1.39 | -15.8% |
| Q2 2025 | August 6, 2025 | $-1.31 | $-1.12 | -17.0% |
| Q1 2025 | May 7, 2025 | $-1.13 | $-1.06 | -6.6% |
| Q4 2024 | February 26, 2025 | $-1.12 | $-0.96 | -16.1% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 14,002,778 | 7.07% | 6.8 | +8.7% |
| June 30, 2026 | 12,882,513 | 6.50% | 3.0 | +4.9% |
| June 15, 2026 | 12,282,512 | 6.20% | 4.3 | +6.0% |
| May 29, 2026 | 11,588,154 | 5.85% | 4.2 | +4.6% |
| May 15, 2026 | 11,075,199 | 5.59% | 4.7 | -13.5% |
| April 30, 2026 | 12,799,582 | 6.73% | 3.3 | -4.4% |
| April 15, 2026 | 13,387,469 | 7.04% | 3.0 | -13.1% |
| March 31, 2026 | 15,409,530 | 8.10% | 7.9 | +6.6% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Revolution Medicines Inc's market cap?
As of August 13, 2026, Revolution Medicines Inc (RVMD) has a market capitalization of $42.92B.
Does Revolution Medicines Inc pay a dividend?
Revolution Medicines Inc does not currently pay a dividend.
What sector is RVMD in?
Revolution Medicines Inc is in the Healthcare sector, specifically the Biotechnology industry.
What is Revolution Medicines Inc's short interest?
As of the July 15, 2026 FINRA settlement, 14,002,778 RVMD shares were sold short, or 7.07% of shares outstanding. Days to cover: 6.8. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Revolution Medicines Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Revolution Medicines Inc reported revenue of $0.00 and net income of -$1.13B.
Ask your own questions about RVMD
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.